GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Vineet Laboratories Ltd (BOM:543298) » Definitions » EV-to-EBIT

Vineet Laboratories (BOM:543298) EV-to-EBIT : 13.48 (As of May. 22, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Vineet Laboratories EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Vineet Laboratories's Enterprise Value is ₹875 Mil. Vineet Laboratories's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was ₹65 Mil. Therefore, Vineet Laboratories's EV-to-EBIT for today is 13.48.

The historical rank and industry rank for Vineet Laboratories's EV-to-EBIT or its related term are showing as below:

BOM:543298' s EV-to-EBIT Range Over the Past 10 Years
Min: 5.71   Med: 13.43   Max: 91.06
Current: 13.48

During the past 7 years, the highest EV-to-EBIT of Vineet Laboratories was 91.06. The lowest was 5.71. And the median was 13.43.

BOM:543298's EV-to-EBIT is ranked better than
62.79% of 1231 companies
in the Chemicals industry
Industry Median: 17.61 vs BOM:543298: 13.48

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Vineet Laboratories's Enterprise Value for the quarter that ended in Dec. 2023 was ₹751 Mil. Vineet Laboratories's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was ₹65 Mil. Vineet Laboratories's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 8.65%.


Vineet Laboratories EV-to-EBIT Historical Data

The historical data trend for Vineet Laboratories's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vineet Laboratories EV-to-EBIT Chart

Vineet Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
EV-to-EBIT
Get a 7-Day Free Trial - - - 5.20 14.50

Vineet Laboratories Quarterly Data
Mar17 Mar18 Mar19 Mar20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.10 14.50 85.73 9.38 11.57

Competitive Comparison of Vineet Laboratories's EV-to-EBIT

For the Chemicals subindustry, Vineet Laboratories's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vineet Laboratories's EV-to-EBIT Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Vineet Laboratories's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Vineet Laboratories's EV-to-EBIT falls into.



Vineet Laboratories EV-to-EBIT Calculation

Vineet Laboratories's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=874.586/64.895
=13.48

Vineet Laboratories's current Enterprise Value is ₹875 Mil.
Vineet Laboratories's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹65 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vineet Laboratories  (BOM:543298) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Vineet Laboratories's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=64.895/750.6117942
=8.65 %

Vineet Laboratories's Enterprise Value for the quarter that ended in Dec. 2023 was ₹751 Mil.
Vineet Laboratories's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹65 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vineet Laboratories EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Vineet Laboratories's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Vineet Laboratories (BOM:543298) Business Description

Traded in Other Exchanges
Address
5-5-160, Malleswari Nilayam, Opposite Vishnu Theatre, Chintalakunta, L.B.Nagar, Hyderabad, TG, IND, 500 074
Vineet Laboratories Ltd Formerly known as Ortin Laboratories Limited, Unit-II is engaged in the business of Pharmaceutical intermediates and Fine chemicals. The products of the companies include Dimethyl phenoxy acetyl chloride, Dimethyl Phenoxy Acetic Acid, Isopropyl-beta-D-thiogalactopyranoside and Nitrophenyl phosphate disodium salt among others. Geographically, the company operates within India and outside India, with a majority of revenue coming from India. The company has one business segment, manufacture of Drug Intermediates & Bulk Dugs.

Vineet Laboratories (BOM:543298) Headlines

No Headlines